BridgeBio Pharma (BBIO) Net Equity Issued and Repurchased (2018 - 2026)
BridgeBio Pharma's Net Equity Issued and Repurchased was -$32.34 million in Q3 2026, compared with $8.02 million a year earlier.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's Net Equity Issued and Repurchased was -$195.85 million through Sep 30, 2026; for FY2025, it came in at -$14.13 million.
- In earlier years, Net Equity Issued and Repurchased was $322.9 million in FY2024 (-29.7%), $459.22 million in FY2023, $8.08 million in FY2022 and -$179.54 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has moved between -$122.28 million (Q2 2026) and $318.16 million (Q1 2024) over five years.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2024 (growth of 755.3%); the worst was Q3 2024 (a decline of 99.3%).
- Per Business Quant data, BBIO's Net Equity Issued and Repurchased in the three quarters before Q3 2026 was -$122.28 million (Q2 2026), -$54.45 million (Q1 2026) and $13.21 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | -32.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -32.34 Mn |
| Jun 30, 2026 | -122.28 Mn |
| Mar 31, 2026 | -54.45 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | 8.02 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | -42.52 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | -254,000.00 |
| Mar 31, 2024 | 318.16 Mn |
| Dec 31, 2023 | 333,000.00 |
| Sep 30, 2023 | 312.71 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 145.02 Mn |
| Dec 31, 2022 | 4.91 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 56,000.00 |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 807,000.00 |
API Access
BridgeBio Pharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();